Zusammenfassung
Eine gestörte Hautbarrierefunktion mit reduzierter Immunkompetenz führt bei Verbrennungspatienten häufig zu Infektionen, die unbehandelt lebensgefährdend sind. Bakterielle Infektionen aus der endogenen Flora oder der Umwelt dominieren. Opportunisten wie Pilzinfektionen nach einer antibakteriellen Therapie stellen eine vitale Bedrohung dar. In der Diagnostik werden klinische, laborchemische und mikrobiologische Parameter erhoben. Maßgeblich ist die Unterscheidung zwischen Kontamination und Infektion. Nach Auswahl eines Antibiotikums sollte die veränderte Pharmakokinetik beim Verbrennungspatienten berücksichtigt werden. Der Nutzen für eine längerfristige antibiotische Prophylaxe ist nicht evident. Leichte Infektionen beim stabilen klinischen Zustand sind engmaschig zu beobachten, während bei schwerer Infektion die internationalen Sepsisleitlinien und das Tarragona-Prinzip empfohlen werden. Systemische Infektionen mit Hefepilzen müssen frühzeitig erkannt werden. Das Nebenwirkungsprofil der begrenzten antimykotischen Auswahl trägt zur schlechten Prognose bei Pilzinfektionen bei.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Avni T, Levcovich A, Ad-El DD, Leibovici L, Paul M (2010) Prophylactic antibiotics for burns patients: systematic review and meta-analysis. Bmj 340:c241. doi:10.1136/bmj.c241
Barajas-Nava LA, Lopez-Alcalde J, Roque i Figuls M, Sola I, Bonfill Cosp X (2013) Antibiotic prophylaxis for preventing burn wound infection. Cochrane Database Syst Rev 6:Cd008738. doi:10.1002/14651858.CD008738.pub2
Beck S, Wicha SG, Kloft C, Kees MG (2014) [Pharmacokinetics and pharmacodynamics of antibiotic therapy]. Anaesthesist 63 (10):775-782. doi:10.1007/s00101-014-2369-9
Bordes J, Maslin J, Prunet B, d’Aranda E, Lacroix G, Goutorbe P, Dantzer E, Meaudre E (2011) Cytomegalovirus infection in severe burn patients monitoring by real-time polymerase chain reaction: A prospective study. Burns 37 (3):434–439. doi:10.1016/j.burns.2010.11.006
Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, Perrin D, Fieux F, Aubas S (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. Jama 290 (19):2588-2598. doi:10.1001/jama.290.19.2588
De La Cal MA, Cerda E, Garcia-Hierro P, Van Saene HK, Gomez-Santos D, Negro E, Lorente JA (2005) Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomized, placebo-controlled, double-blind trial. Ann Surg 241 (3):424–430
De Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, van der Hoeven JG, Pickkers P, Bogaers-Hofman D, van der Meer NJ, Bernards AT, Kuijper EJ, Joore JC, Leverstein-van Hall MA, Bindels AJ, Jansz AR, Wesselink RM, de Jongh BM, Dennesen PJ, van Asselt GJ, te Velde LF, Frenay IH, Kaasjager K, Bosch FH, van Iterson M, Thijsen SF, Kluge GH, Pauw W, de Vries JW, Kaan JA, Arends JP, Aarts LP, Sturm PD, Harinck HI, Voss A, Uijtendaal EV, Blok HE, Thieme Groen ES, Pouw ME, Kalkman CJ, Bonten MJ (2009) Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 360 (1):20–31. doi:10.1056/NEJMoa0800394
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39 (2):165–228. doi:10.1007/s00134-012-2769-8
Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Starr T, Paul SK, Lipman J (2015) A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. Am J Respir Crit Care Med. doi:10.1164/rccm.201505-0857OC
Ergun O, Celik A, Ergun G, Ozok G (2004) Prophylactic antibiotic use in pediatric burn units. Eur J Pediatr Surg 14 (6):422–426. doi:10.1055/s-2004-821065
Greenhalgh DG, Saffle JR, Holmes JHt, Gamelli RL, Palmieri TL, Horton JW, Tompkins RG, Traber DL, Mozingo DW, Deitch EA, Goodwin CW, Herndon DN, Gallagher JJ, Sanford AP, Jeng JC, Ahrenholz DH, Neely AN, O’Mara MS, Wolf SE, Purdue GF, Garner WL, Yowler CJ, Latenser BA (2007) American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res 28 (6):776–790. doi:10.1097/BCR.0b013e3181599bc9
Ha JF, Italiano CM, Heath CH, Shih S, Rea S, Wood FM (2011) Candidemia and invasive candidiasis: a review of the literature for the burns surgeon. Burns 37 (2):181–195. doi:10.1016/j.burns.2010.01.005
Horvath EE, Murray CK, Vaughan GM, Chung KK, Hospenthal DR, Wade CE, Holcomb JB, Wolf SE, Mason AD, Cancio LC (2007) Fungal wound infection (not colonization) is independently associated with mortality in burn patients Ann Surg 245, 978–985. doi:10.1097/01.sla.0000256914.16754.80
Huttner A, Harbarth S, Hope WW, Lipman J, Roberts JA (2015) Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for? J Antimicrob Chemother. doi:10.1093/jac/dkv201
Jensen JU, Hein L, Lundgren B, Bestle MH, Mohr TT, Andersen MH, Thornberg KJ, Loken J, Steensen M, Fox Z, Tousi H, Soe-Jensen P, Lauritsen AO, Strange D, Petersen PL, Reiter N, Hestad S, Thormar K, Fjeldborg P, Larsen KM, Drenck NE, Ostergaard C, Kjaer J, Grarup J, Lundgren JD (2011) Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 39 (9):2048–2058. doi:10.1097/CCM.0b013e31821e8791
Kollef MH, Micek ST (2005) Strategies to prevent antimicrobial resistance in the intensive care unit. Crit Care Med 33 (8):1845–1853
KRINKO (2012) Hygienemaßnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stäbchen Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut (RKI). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55 (10):1311–1354. doi:10.1007/s00103-012-1549-5
Krueger WA, Bulitta J, Kinzig-Schippers M, Landersdorfer C, Holzgrabe U, Naber KG, Drusano GL, Sorgel F (2005) Evaluation by monte carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers. Antimicrob Agents Chemother 49 (5):1881–1889. doi:10.1128/aac.49.5.1881-1889.2005
Latenser BA (2009) Critical care of the burn patient: the first 48 hours. Crit Care Med 37 (10):2819–2826. doi:10.1097/CCM.0b013e3181b3a08f
León, C, Ruiz-Santana, S, Saavedra, P, Almirante, B, Nolla-Salas, J, Alvarez-Lerma, F, Garnacho-Montero, J, León, MA (2006) A bedside scoring system (»Candida score«) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 34, 730–737. doi:10.1097/01.CCM.0000202208.37364.7D
Mann EA, Wood GL, Wade CE (2011) Use of procalcitonin for the detection of sepsis in the critically ill burn patient: a systematic review of the literature. Burns 37 (4):549–558. doi:10.1016/j.burns.2010.04.013
Matthaiou DK, Christodoulopoulou T, Dimopoulos G (2015) How to treat fungal infections in ICU patients. BMC Infect Dis 15:205. doi:10.1186/s12879-015-0934-8
Matthaiou DK, Ntani G, Kontogiorgi M, Poulakou G, Armaganidis A, Dimopoulos G (2012) An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients. Intensive Care Med 38 (6):940–949. doi:10.1007/s00134-012-2563-7
Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48 (5):503-535. doi:10.1086/596757
Rafla K, Tredget EE (2011) Infection control in the burn unit. Burns 37 (1):5–15. doi:10.1016/j.burns.2009.06.198
Ravat F, Le-Floch R, Vinsonneau C, Ainaud P, Bertin-Maghit M, Carsin H, Perro G (2011) Antibiotics and the burn patient. Burns 37 (1):16–26. doi:10.1016/j.burns.2009.10.006
Ren H, Li Y, Han C, Hu H (2015) Serum procalcitonin as a diagnostic biomarker for sepsis in burned patients: a meta-analysis. Burns 41 (3):502–509. doi:10.1016/j.burns.2014.08.019
Roberts JA, Kirkpatrick CM, Roberts MS, Robertson TA, Dalley AJ, Lipman J (2009) Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution. J Antimicrob Chemother 64 (1):142-150. doi:10.1093/jac/dkp139
Roberts JA, Lipman J (2009) Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 37 (3):840–851; quiz 859. doi:10.1097/CCM.0b013e3181961bff
Sandiumenge A, Diaz E, Bodi M, Rello J (2003) Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of “The Tarragona Strategy”. Intensive Care Med 29 (6):876–883. doi:10.1007/s00134-003-1715-1
Schofield CM, Murray CK, Horvath EE, Cancio LC, Kim SH, Wolf SE, Hospenthal DR (2007) Correlation of culture with histopathology in fungal burn wound colonization and infection. Burns 33, 341–346. doi:10.1016/j.burns.2006.08.040
Ugburo AO, Atoyebi OA, Oyeneyin JO, Sowemimo GO (2004) An evaluation of the role of systemic antibiotic prophylaxis in the control of burn wound infection at the Lagos University Teaching Hospital. Burns 30 (1):43–48
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hohn, A., Zahn, P.K., Sakka, S.G., Mikhail, B.D. (2016). Antiinfektive Therapie. In: Lehnhardt, M., Hartmann, B., Reichert, B. (eds) Verbrennungschirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54444-6_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-54444-6_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54443-9
Online ISBN: 978-3-642-54444-6
eBook Packages: Medicine (German Language)